Dogwood Therapeutics Ownership | Who Owns Dogwood Therapeutics?

Dogwood Therapeutics Ownership Summary

Dogwood Therapeutics is owned by 10.79% institutional investors, 74.49% insiders, and 14.72% retail investors.

DWTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Dogwood Therapeutics	10.79%	74.49%	14.72%
Sector	Healthcare Stocks	35.49%	11.75%	52.76%
Industry	Biotech Stocks	34.83%	11.71%	53.46%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	13	30.00%	3,619,770	5057.10%	10	4618.25%	9	80.00%	-	-100.00%
Dec 31, 2025	10	-16.67%	70,190	80.45%	-	673.57%	5	-	2	-50.00%
Sep 30, 2025	12	20.00%	38,897	-9.96%	-	302.66%	5	66.67%	4	33.33%
Jun 30, 2025	10	-23.08%	43,200	-47.30%	-	93.36%	3	-62.50%	3	200.00%
Mar 31, 2025	13	30.00%	81,969	166.39%	-	1257.15%	8	-20.00%	1	-

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	-
2025 Q4	-	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-

DWTX Ownership FAQ

Who Owns Dogwood Therapeutics?

Dogwood Therapeutics shareholders are primarily institutional investors at 10.79%, followed by 74.49% insiders and 14.72% retail investors. The average institutional ownership in Dogwood Therapeutics's industry, Biotech Stocks , is 34.83%, which Dogwood Therapeutics falls below.

Does Blackrock own Dogwood Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Dogwood Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools